We are live on ! Find out more
CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

Back to rankings

84 hedge funds and large institutions have $29.5M invested in Carisma Therapeutics in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 31 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.1% less ownership

Funds ownership: 1.22% → 1.11% (-0.1%)

10% less funds holding

Funds holding: 93 → 84 (-9)

17% less call options, than puts

Call options by funds: $934K | Put options by funds: $1.12M

30% less capital invested

Capital invested by funds: $42.2M → $29.5M (-$12.6M)

47% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 15

48% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 31

Holders
84
Holders Change
-9
Holders Change %
-9.68%
% of All Funds
1.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
16
Reduced
31
Closed
15
Calls
$934K
Puts
$1.12M
Net Calls
-$188K
Net Calls Change
+$1.61M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$478K
2
Renaissance Technologies
Renaissance Technologies
New York
+$319K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$229K
4
SWP
Stratos Wealth Partners
Ohio
+$68.5K
5
State Street
State Street
Massachusetts
+$36.5K

Top Sellers

Rank Fund Capital Flow
1
Prudential Financial
Prudential Financial
New Jersey
-$471K
2
Two Sigma Investments
Two Sigma Investments
New York
-$407K
3
Citadel Advisors
Citadel Advisors
Florida
-$402K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$322K
5
Jane Street
Jane Street
New York
-$311K
Name Holding Trade Value Shares
Change 		Change in
Stake
TIM
76
Tortoise Investment Management
New York
$2K – – –
GIA
77
GHP Investment Advisors
Colorado
$2K +$1.94K +139 New
AA
78
Ancora Advisors
Ohio
$1K – – –
National Bank of Canada
79
National Bank of Canada
Quebec, Canada
$1K – – –
SWM
80
Spire Wealth Management
Virginia
$1K +$140 +10 +11%
ZIG
81
Zullo Investment Group
Pennsylvania
$1K +$587 +42 +525%
Two Sigma Investments
82
Two Sigma Investments
New York
– -$407K -24,974 Closed
Marshall Wace
83
Marshall Wace
United Kingdom
– -$308K -18,997 Closed
Two Sigma Advisers
84
Two Sigma Advisers
New York
– -$288K -17,659 Closed
VF
85
Virtu Financial
New York
– -$156K -9,560 Closed
Vontobel Holding
86
Vontobel Holding
Switzerland
– -$94K -5,750 Closed
EGM
87
Engineers Gate Manager
New York
– -$43K -2,645 Closed
Simplex Trading
88
Simplex Trading
Illinois
– -$28.5K -2,037 Closed
SG Americas Securities
89
SG Americas Securities
New York
– -$23K -1,391 Closed
Manulife (Manufacturers Life Insurance)
90
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$22 -1,329 Closed
XT
91
XTX Topco
Cayman Islands
– -$14K -884 Closed
CG
92
Cutler Group
California
– -$11.3K -811 -99%
Millennium Management
93
Millennium Management
New York
– -$12K -718 Closed
Ameriprise
94
Ameriprise
Minnesota
– -$11K -685 Closed
Jacobs Levy Equity Management
95
Jacobs Levy Equity Management
New Jersey
– -$9K -577 Closed
Belvedere Trading
96
Belvedere Trading
Illinois
– -$6K -446 Closed
HFS
97
Hantz Financial Services
Michigan
– +$419 +30 New
1 2 3
4

CARM Hedge Fund Activity: Q1 2022 in Review

84 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Carisma Therapeutics (CARM) for Q1 2022, worth a combined $29.5M — down 30% from $42.2M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of CARM and 8 opened new positions — a net loss of 7 holders — while 31 trimmed existing stakes and 16 added.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $478K. The largest seller was Prudential Financial, cutting an estimated $471K.

  • 84 institutional investors held Carisma Therapeutics (CARM) as of Q1 2022, down from 93 in Q4 2021.
  • Funds reported $29.5M of Carisma Therapeutics stock for Q1 2022, down 30% quarter-over-quarter.
  • 8 funds opened new Carisma Therapeutics positions in Q1 2022 and 15 closed out, a net change of -7 holders.
  • The largest Carisma Therapeutics buyer in Q1 2022 was Fidelity Investments, an estimated $478K added.
  • The largest Carisma Therapeutics seller in Q1 2022 was Prudential Financial, an estimated $471K sold.

Based on aggregated 13F filings for Q1 2022.